Aandelen in “Farmaceutica”

Aandeel Datum Koers Evolutie
Even geduld...

Nieuws over “Farmaceutica”

20/03 · Data from Phase 2b Studies for Rezpegaldesleukin Accepted for Two Oral Presentations at the 2026 American Academy of Dermatology Annual Meeting · Persbericht

20/03 · Data from Phase 2b Studies for Rezpegaldesleukin Accepted for Two Oral Presentations at the 2026 American Academy of Dermatology Annual Meeting · Persbericht

20/03 · Novartis agrees to acquire a pan-mutant-selective PI3Kα inhibitor, strengthening its breast cancer pipeline · Persbericht

19/03 · FDA approves Novo Nordisk's new Wegovy® HD injection, delivering the highest weight loss to date for a Wegovy® injection, adding to its already expansive clinical profile · Persbericht

19/03 · Novo Nordisk A/S: Wegovy® HD (semaglutide 7.2 mg) approved in the US, providing 20.7% mean weight loss · Persbericht

19/03 · Pomerantz Law Firm Announces the Filing of a Class Action Against Nektar Therapeutics, Inc. and Certain Officers - NKTR · Persbericht

19/03 · Viatris to Outline its Vision for Sustained Revenue and Earnings Growth Through 2030 · Persbericht

19/03 · Biohaven's Phase 2 Obesity Study with Taldefgrobep Alfa, a Novel Myostatin-Activin Pathway Inhibitor, Completes Enrollment · Persbericht

19/03 · AC Immune Presents First In vivo Images of Brain TDP-43 Pathology from Phase 1 Trial of PET tracer ACI-19626, at AD/PDTM 2026 · Persbericht

19/03 · Lilly's triple agonist, retatrutide, demonstrated significant reductions in A1C and weight in first Phase 3 trial for treatment of type 2 diabetes · Persbericht

19/03 · Allergan Aesthetics Reveals Evolution in Approach to Modern Aesthetic Treatments with Comprehensive Global Survey and New Educational Solutions · Persbericht

18/03 · GOSS: Management Optimistic About Topline Results -- LEVI & KORSINSKY, LLP Investigates After Trial Fails · Persbericht

18/03 · FDA approval of ICOTYDE™ (icotrokinra) ushers in new era for first-line systemic treatment of plaque psoriasis with a targeted oral peptide · Persbericht

18/03 · Zymeworks Announces Presentations for Ziihera® (zanidatamab-hrii) at 2026 AACR Annual Meeting · Persbericht

18/03 · Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2026 AACR Annual Meeting · Persbericht

18/03 · IDEAYA Biosciences Announces Upcoming Presentations at AACR 2026 Highlighting Multiple Clinical Stage Pipeline Programs · Persbericht

18/03 · Ipsen showcases transformative potential of early immuno-oncology pipeline at AACR · Persbericht

18/03 · Press Release: Sanofi’s venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease · Persbericht

17/03 · Zymeworks to Present Clinical and Preclinical Data on ADC Programs Including Novel RAS ADC Platform at AACR Annual Meeting · Persbericht

17/03 · Vliegtuigaandelen stijgen op in New York · Tijd.be (€)

Wall Street kleurt voorzichtig groen. Delta Air Lines en American Airlines trekken hoger na positieve commentaren van de CEO's. Eli Lilly gaat onderuit door een verkoopadvies van HSBC.

16/03 · NKTR INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Nektar Therapeutics (NKTR) Investors of Securities Class Action Deadline on May 5, 2026 · Persbericht

Mijn selecties